Cargando…
Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study
Study design: A two center, observational study. Introduction: Patient reported outcome (PRO) plays an increasingly important role in the evaluation of novel therapies for tumor patients. It has been shown that tumor treating fields (TTFields) in combination with standard therapy prolong survival in...
Autores principales: | Onken, Julia, Goerling, Ute, Heinrich, Marcel, Pleissner, Stephanie, Krex, Dietmar, Vajkoczy, Peter, Misch, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797850/ https://www.ncbi.nlm.nih.gov/pubmed/31681134 http://dx.doi.org/10.3389/fneur.2019.01026 |
Ejemplares similares
-
Efficacy of TTFields in high-grade gliomas: a protocol for systematic review and meta-analysis
por: Li, Xinlong, et al.
Publicado: (2023) -
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020) -
Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2021) -
Resilience in Lower Grade Glioma Patients
por: Fröhlich, Ellen, et al.
Publicado: (2022) -
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)